FIELD: chemistry.
SUBSTANCE: group of inventions relates to medicine. Disclosed a pharmaceutical composition containing crystalline modification of β2,3-bis-(hydroxymethyl)quinoxaline-N,N'-dioxide, characterised by a number of diffraction peaks (d, Ǻ) and their intensity (Irel., %), and silver nanoparticles. Disclosed production process. Antimicrobial, antibacterial and bactericidal pharmaceutical composition, comprising crystalline β-modification of 2,3-bis-(hydroxymethyl)quinoxaline-N,N'-dioxide, characterised by a number of diffraction peaks (d, Ǻ) and their intensity (Irel., %), and silver nanoparticles, constitutes a light fluffy powder of yellowish to light-brown colour, non-odorous.
EFFECT: disclosed the said pharmaceutical composition and method for obtaining thereof.
7 cl, 6 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CRYSTALLINE β-MODIFICATION OF 2,3-BIS-(HYDROXYMETHYL)QUINOXALINE-N,N'-DIOXIDE, METHOD OF THEREOF OBTAINING AND THEREOF-BASED PHARMACEUTICAL COMPOSITION | 2014 |
|
RU2563256C1 |
| LOCAL HAEMOSTATIC ANTIBACTERIAL AGENT | 2021 |
|
RU2776015C1 |
| NEW COMPOSITIONS OF 2,3-BIS-(HYDROXYMETHYL)QUINOXALINE 1,4-DI-N-OXIDE FOR TOPICAL APPLICATION | 2021 |
|
RU2791248C2 |
| ANTISEPTIC COMPOSITION "CHLORDIX" | 2007 |
|
RU2351365C2 |
| METHOD FOR STERILISATION AND PRE-IMPLANTATION STORAGE OF BIOLOGICAL PROSTHESES OF XENOGENIC AND ALLOGENIC TISSUE FOR CARDIOVASCULAR SURGERY | 2011 |
|
RU2457867C1 |
| BIOACTIVE HYDROGEL BASED ON HIGH MOLECULAR WEIGHT CHITOSAN AND METHOD OF ITS EXTEMPORANEOUS PRODUCTION | 2021 |
|
RU2810573C2 |
| PHARMACEUTICAL COMBINED COMPOSITION FOR LOCAL AND EXTERNAL USE ON BASIS OF DIOXIDINE | 2016 |
|
RU2667974C2 |
| PHARMACEUTICAL COMBINED COMPOSITION FOR LOCAL AND EXTERNAL USE ON BASIS OF BACTERIOLYTIC AND PROTEOLYTIC COMPLEX OF ENZYMES | 2016 |
|
RU2655808C2 |
| HOOF HYGIENIC PRODUCT | 2019 |
|
RU2729193C1 |
| COMPOSITION WITH LONG-LASTING BIOCIDAL EFFECT AND THE COMPOSITION MOUTHWASH | 2022 |
|
RU2788728C1 |
